Warning signs to watch for when shopping for online GLP-1 care.
Red flags
- Guaranteed prescription before clinician review
- No clear prescriber identity
- No clear dispensing pharmacy
- Claims that compounded products are FDA-approved
- Claims that compounded products are generic Wegovy/Zepbound without support
- Unclear concentration or dosing instructions
- Pressure to purchase without explaining cancellation or refund terms
Why FDA scrutiny increased
In 2026 FDA announced warning letters to telehealth companies over false or misleading compounded-GLP-1 claims and continued to publicize concerns about fraudulent products.
What good transparency looks like
A responsible service clearly identifies the treatment category, requires clinician review, explains compounded-product status when applicable, and makes support channels visible.
Sources & verification
We use primary sources for time-sensitive commercial and regulatory claims.
- FDA — Concerns with unapproved GLP-1 drugs used for weight loss
- FDA — Warning letters to telehealth companies about compounded GLP-1 marketing
Last reviewed: August 19, 2026